Related Experiment Video
Updated: Jul 18, 2026
09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Sphingolipids in tumor metastases and angiogenesis
E V Dyatlovitskaya1, A G Kandyba
1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia. dyatl@ibch.ru
Biochemistry. Biokhimiia
|April 18, 2006
Summary
Sphingolipids, including S1P and gangliosides, are key players in tumor metastasis and angiogenesis. This review details their roles in cancer progression and the formation of new blood vessels.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Sphingolipids are a diverse class of lipids involved in numerous cellular processes.
- Tumor metastasis and angiogenesis are critical hallmarks of cancer progression.
Purpose of the Study:
- To review and synthesize current data on the involvement of specific sphingolipids in tumor metastasis.
- To summarize the role of sphingolipids in the process of angiogenesis.
Main Methods:
- Literature review of existing research on sphingolipids, tumor metastasis, and angiogenesis.
- Analysis of data linking sphingolipid metabolism and function to cancer progression.
Main Results:
- Sphingolipids such as sphingosine-1-phosphate (S1P) and gangliosides are implicated in promoting tumor cell migration and invasion.
- Sphingolipids influence the formation of new blood vessels (angiogenesis) that support tumor growth.
- Specific sphingolipids can modulate the tumor microenvironment to facilitate metastasis.
Conclusions:
- Sphingolipids represent a significant area of research for understanding and potentially targeting cancer metastasis and angiogenesis.
- Further investigation into sphingolipid pathways may reveal novel therapeutic strategies for cancer treatment.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...